Global Vaccine Conjugate Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaccine Conjugate Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Vaccine Conjugate by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Vaccine Conjugate by Country/Region, 2017, 2022 & 2028

2.2 Vaccine Conjugate Segment by Type

2.2.1 Hib Vaccine

2.2.2 Meningococcal Vaccine

2.2.3 Pneumococcal Vaccine

2.2.4 Others

2.3 Vaccine Conjugate Sales by Type

2.3.1 Global Vaccine Conjugate Sales Market Share by Type (2017-2022)

2.3.2 Global Vaccine Conjugate Revenue and Market Share by Type (2017-2022)

2.3.3 Global Vaccine Conjugate Sale Price by Type (2017-2022)

2.4 Vaccine Conjugate Segment by Application

2.4.1 Children

2.4.2 Adult

2.5 Vaccine Conjugate Sales by Application

2.5.1 Global Vaccine Conjugate Sale Market Share by Application (2017-2022)

2.5.2 Global Vaccine Conjugate Revenue and Market Share by Application (2017-2022)

2.5.3 Global Vaccine Conjugate Sale Price by Application (2017-2022)

3 Global Vaccine Conjugate by Company

3.1 Global Vaccine Conjugate Breakdown Data by Company

3.1.1 Global Vaccine Conjugate Annual Sales by Company (2020-2022)

3.1.2 Global Vaccine Conjugate Sales Market Share by Company (2020-2022)

3.2 Global Vaccine Conjugate Annual Revenue by Company (2020-2022)

3.2.1 Global Vaccine Conjugate Revenue by Company (2020-2022)

3.2.2 Global Vaccine Conjugate Revenue Market Share by Company (2020-2022)

3.3 Global Vaccine Conjugate Sale Price by Company

3.4 Key Manufacturers Vaccine Conjugate Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vaccine Conjugate Product Location Distribution

3.4.2 Players Vaccine Conjugate Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Vaccine Conjugate by Geographic Region

4.1 World Historic Vaccine Conjugate Market Size by Geographic Region (2017-2022)

4.1.1 Global Vaccine Conjugate Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Vaccine Conjugate Annual Revenue by Geographic Region

4.2 World Historic Vaccine Conjugate Market Size by Country/Region (2017-2022)

4.2.1 Global Vaccine Conjugate Annual Sales by Country/Region (2017-2022)

4.2.2 Global Vaccine Conjugate Annual Revenue by Country/Region

4.3 Americas Vaccine Conjugate Sales Growth

4.4 APAC Vaccine Conjugate Sales Growth

4.5 Europe Vaccine Conjugate Sales Growth

4.6 Middle East & Africa Vaccine Conjugate Sales Growth

5 Americas

5.1 Americas Vaccine Conjugate Sales by Country

5.1.1 Americas Vaccine Conjugate Sales by Country (2017-2022)

5.1.2 Americas Vaccine Conjugate Revenue by Country (2017-2022)

5.2 Americas Vaccine Conjugate Sales by Type

5.3 Americas Vaccine Conjugate Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaccine Conjugate Sales by Region

6.1.1 APAC Vaccine Conjugate Sales by Region (2017-2022)

6.1.2 APAC Vaccine Conjugate Revenue by Region (2017-2022)

6.2 APAC Vaccine Conjugate Sales by Type

6.3 APAC Vaccine Conjugate Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Vaccine Conjugate by Country

7.1.1 Europe Vaccine Conjugate Sales by Country (2017-2022)

7.1.2 Europe Vaccine Conjugate Revenue by Country (2017-2022)

7.2 Europe Vaccine Conjugate Sales by Type

7.3 Europe Vaccine Conjugate Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaccine Conjugate by Country

8.1.1 Middle East & Africa Vaccine Conjugate Sales by Country (2017-2022)

8.1.2 Middle East & Africa Vaccine Conjugate Revenue by Country (2017-2022)

8.2 Middle East & Africa Vaccine Conjugate Sales by Type

8.3 Middle East & Africa Vaccine Conjugate Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Vaccine Conjugate

10.3 Manufacturing Process Analysis of Vaccine Conjugate

10.4 Industry Chain Structure of Vaccine Conjugate

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Vaccine Conjugate Distributors

11.3 Vaccine Conjugate Customer

12 World Forecast Review for Vaccine Conjugate by Geographic Region

12.1 Global Vaccine Conjugate Market Size Forecast by Region

12.1.1 Global Vaccine Conjugate Forecast by Region (2023-2028)

12.1.2 Global Vaccine Conjugate Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Vaccine Conjugate Forecast by Type

12.7 Global Vaccine Conjugate Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Vaccine Conjugate Product Offered

13.1.3 Pfizer Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Vaccine Conjugate Product Offered

13.2.3 GSK Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Vaccine Conjugate Product Offered

13.3.3 Sanofi Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Merck

13.4.1 Merck Company Information

13.4.2 Merck Vaccine Conjugate Product Offered

13.4.3 Merck Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck Main Business Overview

13.4.5 Merck Latest Developments

13.5 Walvax Biotechnology

13.5.1 Walvax Biotechnology Company Information

13.5.2 Walvax Biotechnology Vaccine Conjugate Product Offered

13.5.3 Walvax Biotechnology Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Walvax Biotechnology Main Business Overview

13.5.5 Walvax Biotechnology Latest Developments

13.6 Royal (Wuxi) Bio-Pharmaceutical

13.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Information

13.6.2 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Product Offered

13.6.3 Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Royal (Wuxi) Bio-Pharmaceutical Main Business Overview

13.6.5 Royal (Wuxi) Bio-Pharmaceutical Latest Developments

13.7 Bharat Biotech

13.7.1 Bharat Biotech Company Information

13.7.2 Bharat Biotech Vaccine Conjugate Product Offered

13.7.3 Bharat Biotech Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Bharat Biotech Main Business Overview

13.7.5 Bharat Biotech Latest Developments

13.8 Zhifei Biologic

13.8.1 Zhifei Biologic Company Information

13.8.2 Zhifei Biologic Vaccine Conjugate Product Offered

13.8.3 Zhifei Biologic Vaccine Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Zhifei Biologic Main Business Overview

13.8.5 Zhifei Biologic Latest Developments

14 Research Findings and Conclusion

Table 1. Vaccine Conjugate Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Vaccine Conjugate Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Hib Vaccine

Table 4. Major Players of Meningococcal Vaccine

Table 5. Major Players of Pneumococcal Vaccine

Table 6. Major Players of Others

Table 7. Global Vaccine Conjugate Sales by Type (2017-2022) & (K Doses)

Table 8. Global Vaccine Conjugate Sales Market Share by Type (2017-2022)

Table 9. Global Vaccine Conjugate Revenue by Type (2017-2022) & ($ million)

Table 10. Global Vaccine Conjugate Revenue Market Share by Type (2017-2022)

Table 11. Global Vaccine Conjugate Sale Price by Type (2017-2022) & (USD/Dose)

Table 12. Global Vaccine Conjugate Sales by Application (2017-2022) & (K Doses)

Table 13. Global Vaccine Conjugate Sales Market Share by Application (2017-2022)

Table 14. Global Vaccine Conjugate Revenue by Application (2017-2022)

Table 15. Global Vaccine Conjugate Revenue Market Share by Application (2017-2022)

Table 16. Global Vaccine Conjugate Sale Price by Application (2017-2022) & (USD/Dose)

Table 17. Global Vaccine Conjugate Sales by Company (2020-2022) & (K Doses)

Table 18. Global Vaccine Conjugate Sales Market Share by Company (2020-2022)

Table 19. Global Vaccine Conjugate Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Vaccine Conjugate Revenue Market Share by Company (2020-2022)

Table 21. Global Vaccine Conjugate Sale Price by Company (2020-2022) & (USD/Dose)

Table 22. Key Manufacturers Vaccine Conjugate Producing Area Distribution and Sales Area

Table 23. Players Vaccine Conjugate Products Offered

Table 24. Vaccine Conjugate Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Vaccine Conjugate Sales by Geographic Region (2017-2022) & (K Doses)

Table 28. Global Vaccine Conjugate Sales Market Share Geographic Region (2017-2022)

Table 29. Global Vaccine Conjugate Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Vaccine Conjugate Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Vaccine Conjugate Sales by Country/Region (2017-2022) & (K Doses)

Table 32. Global Vaccine Conjugate Sales Market Share by Country/Region (2017-2022)

Table 33. Global Vaccine Conjugate Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Vaccine Conjugate Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Vaccine Conjugate Sales by Country (2017-2022) & (K Doses)

Table 36. Americas Vaccine Conjugate Sales Market Share by Country (2017-2022)

Table 37. Americas Vaccine Conjugate Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Vaccine Conjugate Revenue Market Share by Country (2017-2022)

Table 39. Americas Vaccine Conjugate Sales by Type (2017-2022) & (K Doses)

Table 40. Americas Vaccine Conjugate Sales Market Share by Type (2017-2022)

Table 41. Americas Vaccine Conjugate Sales by Application (2017-2022) & (K Doses)

Table 42. Americas Vaccine Conjugate Sales Market Share by Application (2017-2022)

Table 43. APAC Vaccine Conjugate Sales by Region (2017-2022) & (K Doses)

Table 44. APAC Vaccine Conjugate Sales Market Share by Region (2017-2022)

Table 45. APAC Vaccine Conjugate Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Vaccine Conjugate Revenue Market Share by Region (2017-2022)

Table 47. APAC Vaccine Conjugate Sales by Type (2017-2022) & (K Doses)

Table 48. APAC Vaccine Conjugate Sales Market Share by Type (2017-2022)

Table 49. APAC Vaccine Conjugate Sales by Application (2017-2022) & (K Doses)

Table 50. APAC Vaccine Conjugate Sales Market Share by Application (2017-2022)

Table 51. Europe Vaccine Conjugate Sales by Country (2017-2022) & (K Doses)

Table 52. Europe Vaccine Conjugate Sales Market Share by Country (2017-2022)

Table 53. Europe Vaccine Conjugate Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Vaccine Conjugate Revenue Market Share by Country (2017-2022)

Table 55. Europe Vaccine Conjugate Sales by Type (2017-2022) & (K Doses)

Table 56. Europe Vaccine Conjugate Sales Market Share by Type (2017-2022)

Table 57. Europe Vaccine Conjugate Sales by Application (2017-2022) & (K Doses)

Table 58. Europe Vaccine Conjugate Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Vaccine Conjugate Sales by Country (2017-2022) & (K Doses)

Table 60. Middle East & Africa Vaccine Conjugate Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Vaccine Conjugate Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Vaccine Conjugate Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Vaccine Conjugate Sales by Type (2017-2022) & (K Doses)

Table 64. Middle East & Africa Vaccine Conjugate Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Vaccine Conjugate Sales by Application (2017-2022) & (K Doses)

Table 66. Middle East & Africa Vaccine Conjugate Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Vaccine Conjugate

Table 68. Key Market Challenges & Risks of Vaccine Conjugate

Table 69. Key Industry Trends of Vaccine Conjugate

Table 70. Vaccine Conjugate Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Vaccine Conjugate Distributors List

Table 73. Vaccine Conjugate Customer List

Table 74. Global Vaccine Conjugate Sales Forecast by Region (2023-2028) & (K Doses)

Table 75. Global Vaccine Conjugate Sales Market Forecast by Region

Table 76. Global Vaccine Conjugate Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Vaccine Conjugate Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Vaccine Conjugate Sales Forecast by Country (2023-2028) & (K Doses)

Table 79. Americas Vaccine Conjugate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Vaccine Conjugate Sales Forecast by Region (2023-2028) & (K Doses)

Table 81. APAC Vaccine Conjugate Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Vaccine Conjugate Sales Forecast by Country (2023-2028) & (K Doses)

Table 83. Europe Vaccine Conjugate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Vaccine Conjugate Sales Forecast by Country (2023-2028) & (K Doses)

Table 85. Middle East & Africa Vaccine Conjugate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Vaccine Conjugate Sales Forecast by Type (2023-2028) & (K Doses)

Table 87. Global Vaccine Conjugate Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Vaccine Conjugate Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Vaccine Conjugate Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Vaccine Conjugate Sales Forecast by Application (2023-2028) & (K Doses)

Table 91. Global Vaccine Conjugate Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Vaccine Conjugate Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Vaccine Conjugate Revenue Market Share Forecast by Application (2023-2028)

Table 94. Pfizer Basic Information, Vaccine Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 95. Pfizer Vaccine Conjugate Product Offered

Table 96. Pfizer Vaccine Conjugate Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 97. Pfizer Main Business

Table 98. Pfizer Latest Developments

Table 99. GSK Basic Information, Vaccine Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 100. GSK Vaccine Conjugate Product Offered

Table 101. GSK Vaccine Conjugate Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 102. GSK Main Business

Table 103. GSK Latest Developments

Table 104. Sanofi Basic Information, Vaccine Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 105. Sanofi Vaccine Conjugate Product Offered

Table 106. Sanofi Vaccine Conjugate Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 107. Sanofi Main Business

Table 108. Sanofi Latest Developments

Table 109. Merck Basic Information, Vaccine Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 110. Merck Vaccine Conjugate Product Offered

Table 111. Merck Vaccine Conjugate Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 112. Merck Main Business

Table 113. Merck Latest Developments

Table 114. Walvax Biotechnology Basic Information, Vaccine Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 115. Walvax Biotechnology Vaccine Conjugate Product Offered

Table 116. Walvax Biotechnology Vaccine Conjugate Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 117. Walvax Biotechnology Main Business

Table 118. Walvax Biotechnology Latest Developments

Table 119. Royal (Wuxi) Bio-Pharmaceutical Basic Information, Vaccine Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 120. Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Product Offered

Table 121. Royal (Wuxi) Bio-Pharmaceutical Vaccine Conjugate Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 122. Royal (Wuxi) Bio-Pharmaceutical Main Business

Table 123. Royal (Wuxi) Bio-Pharmaceutical Latest Developments

Table 124. Bharat Biotech Basic Information, Vaccine Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 125. Bharat Biotech Vaccine Conjugate Product Offered

Table 126. Bharat Biotech Vaccine Conjugate Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 127. Bharat Biotech Main Business

Table 128. Bharat Biotech Latest Developments

Table 129. Zhifei Biologic Basic Information, Vaccine Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 130. Zhifei Biologic Vaccine Conjugate Product Offered

Table 131. Zhifei Biologic Vaccine Conjugate Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 132. Zhifei Biologic Main Business

Table 133. Zhifei Biologic Latest Developments

List of Figures

Figure 1. Picture of Vaccine Conjugate

Figure 2. Vaccine Conjugate Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vaccine Conjugate Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Vaccine Conjugate Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Vaccine Conjugate Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Hib Vaccine

Figure 10. Product Picture of Meningococcal Vaccine

Figure 11. Product Picture of Pneumococcal Vaccine

Figure 12. Product Picture of Others

Figure 13. Global Vaccine Conjugate Sales Market Share by Type in 2021

Figure 14. Global Vaccine Conjugate Revenue Market Share by Type (2017-2022)

Figure 15. Vaccine Conjugate Consumed in Children

Figure 16. Global Vaccine Conjugate Market: Children (2017-2022) & (K Doses)

Figure 17. Vaccine Conjugate Consumed in Adult

Figure 18. Global Vaccine Conjugate Market: Adult (2017-2022) & (K Doses)

Figure 19. Global Vaccine Conjugate Sales Market Share by Application (2017-2022)

Figure 20. Global Vaccine Conjugate Revenue Market Share by Application in 2021

Figure 21. Vaccine Conjugate Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Vaccine Conjugate Revenue Market Share by Company in 2021

Figure 23. Global Vaccine Conjugate Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Vaccine Conjugate Revenue Market Share by Geographic Region in 2021

Figure 25. Global Vaccine Conjugate Sales Market Share by Region (2017-2022)

Figure 26. Global Vaccine Conjugate Revenue Market Share by Country/Region in 2021

Figure 27. Americas Vaccine Conjugate Sales 2017-2022 (K Doses)

Figure 28. Americas Vaccine Conjugate Revenue 2017-2022 ($ Millions)

Figure 29. APAC Vaccine Conjugate Sales 2017-2022 (K Doses)

Figure 30. APAC Vaccine Conjugate Revenue 2017-2022 ($ Millions)

Figure 31. Europe Vaccine Conjugate Sales 2017-2022 (K Doses)

Figure 32. Europe Vaccine Conjugate Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Vaccine Conjugate Sales 2017-2022 (K Doses)

Figure 34. Middle East & Africa Vaccine Conjugate Revenue 2017-2022 ($ Millions)

Figure 35. Americas Vaccine Conjugate Sales Market Share by Country in 2021

Figure 36. Americas Vaccine Conjugate Revenue Market Share by Country in 2021

Figure 37. United States Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Vaccine Conjugate Sales Market Share by Region in 2021

Figure 42. APAC Vaccine Conjugate Revenue Market Share by Regions in 2021

Figure 43. China Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Vaccine Conjugate Sales Market Share by Country in 2021

Figure 50. Europe Vaccine Conjugate Revenue Market Share by Country in 2021

Figure 51. Germany Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Vaccine Conjugate Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Vaccine Conjugate Revenue Market Share by Country in 2021

Figure 58. Egypt Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Vaccine Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Vaccine Conjugate in 2021

Figure 64. Manufacturing Process Analysis of Vaccine Conjugate

Figure 65. Industry Chain Structure of Vaccine Conjugate

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles